Wei Jiatai, Xie Zijie, Kuang Xiaodong
The Second Clinical Medical College, Nanchang University, Nanchang 330031, China.
Pathology Teaching and Research Office, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
Renal inflammatory diseases are a group of severe conditions marked by significant morbidity and mortality. Extracellular vesicles (EVs), as facilitators of intercellular communication, have been recognized as pivotal regulators of renal inflammatory diseases, significantly contributing to these conditions by modulating immune responses among other mechanisms. This review highlights the intricate mechanisms through which EVs modulate macrophage-kidney cell interactions by regulating macrophages, the principal immune cells within the renal milieu. This regulation subsequently influences the pathophysiology of renal inflammatory diseases such as acute kidney injury and chronic kidney disease. Furthermore, understanding these mechanisms offers novel opportunities to alleviate the severe consequences associated with renal inflammatory diseases. In addition, we summarize the therapeutic landscape based on EV-mediated macrophage regulatory mechanisms, highlighting the potential of EVs as biomarkers and therapeutic targets as well as the challenges and limitations of translating therapies into clinical practice.
肾脏炎性疾病是一组具有显著发病率和死亡率的严重病症。细胞外囊泡(EVs)作为细胞间通讯的促进者,已被公认为肾脏炎性疾病的关键调节因子,通过调节免疫反应等机制对这些病症产生重大影响。本综述重点介绍了细胞外囊泡通过调节巨噬细胞(肾脏微环境中的主要免疫细胞)来调节巨噬细胞与肾脏细胞相互作用的复杂机制。这种调节随后会影响诸如急性肾损伤和慢性肾病等肾脏炎性疾病的病理生理学。此外,了解这些机制为减轻与肾脏炎性疾病相关的严重后果提供了新的机会。此外,我们基于细胞外囊泡介导的巨噬细胞调节机制总结了治疗前景,强调了细胞外囊泡作为生物标志物和治疗靶点的潜力,以及将治疗方法转化为临床实践所面临的挑战和局限性。
Int J Mol Sci. 2021-6-20
Stem Cell Res Ther. 2017-12-4
Am J Physiol Renal Physiol. 2016-11-1
Int J Mol Sci. 2016-6-30
Eur J Pharmacol. 2024-9-5
Int Immunopharmacol. 2021-11
Cytokine Growth Factor Rev. 2024-4
Nat Rev Nephrol. 2025-3-18
Am J Physiol Renal Physiol. 2025-1-1
Front Immunol. 2024
Nat Rev Nephrol. 2025-1
Trends Biotechnol. 2025-1